JP2005526085A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005526085A5 JP2005526085A5 JP2003575997A JP2003575997A JP2005526085A5 JP 2005526085 A5 JP2005526085 A5 JP 2005526085A5 JP 2003575997 A JP2003575997 A JP 2003575997A JP 2003575997 A JP2003575997 A JP 2003575997A JP 2005526085 A5 JP2005526085 A5 JP 2005526085A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- quinolin
- imidazo
- antigen
- amine derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0206461.6A GB0206461D0 (en) | 2002-03-19 | 2002-03-19 | Improvements in vaccination |
| PCT/EP2003/002878 WO2003077944A1 (en) | 2002-03-19 | 2003-03-18 | Improvements in vaccination |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005526085A JP2005526085A (ja) | 2005-09-02 |
| JP2005526085A5 true JP2005526085A5 (enExample) | 2006-03-30 |
Family
ID=9933281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003575997A Pending JP2005526085A (ja) | 2002-03-19 | 2003-03-18 | ワクチン接種の改良 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20050143284A1 (enExample) |
| EP (1) | EP1485125A1 (enExample) |
| JP (1) | JP2005526085A (enExample) |
| AU (1) | AU2003212369A1 (enExample) |
| CA (1) | CA2479315A1 (enExample) |
| GB (1) | GB0206461D0 (enExample) |
| WO (1) | WO2003077944A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003216851B2 (en) * | 2002-03-19 | 2008-04-17 | Powderject Research Limited | Imidazoquinoline adjuvants for vaccines |
| JP2006513212A (ja) | 2002-12-20 | 2006-04-20 | スリーエム イノベイティブ プロパティズ カンパニー | アリール／ヘタリール置換されたイミダゾキノリン |
| US7731967B2 (en) | 2003-04-30 | 2010-06-08 | Novartis Vaccines And Diagnostics, Inc. | Compositions for inducing immune responses |
| JP2007501252A (ja) * | 2003-08-05 | 2007-01-25 | スリーエム イノベイティブ プロパティズ カンパニー | 免疫応答調整剤を含有する製剤 |
| US20050048072A1 (en) * | 2003-08-25 | 2005-03-03 | 3M Innovative Properties Company | Immunostimulatory combinations and treatments |
| US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
| US8871782B2 (en) | 2003-10-03 | 2014-10-28 | 3M Innovative Properties Company | Alkoxy substituted imidazoquinolines |
| WO2005035779A2 (en) * | 2003-10-10 | 2005-04-21 | Powderject Vaccines, Inc | Method |
| AR046781A1 (es) | 2003-11-25 | 2005-12-21 | 3M Innovative Properties Co | Derivados de imidazoquinolinas. composiciones farmaceuticas. |
| WO2006038923A2 (en) | 2004-06-18 | 2006-04-13 | 3M Innovative Properties Company | Aryl substituted imidazonaphthyridines |
| AU2006210392A1 (en) | 2005-02-04 | 2006-08-10 | Coley Pharmaceutical Group, Inc. | Aqueous gel formulations containing immune response modifiers |
| CA2620182A1 (en) | 2005-08-22 | 2007-03-01 | Dennis A. Carson | Tlr agonists |
| ZA200803029B (en) | 2005-09-09 | 2009-02-25 | Coley Pharm Group Inc | Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods |
| AU2006287270A1 (en) | 2005-09-09 | 2007-03-15 | Coley Pharmaceutical Group, Inc. | Amide and carbamate derivatives of N-{2-[4-amino-2- (ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-1,1-dimethylethyl}methanesulfonamide and methods |
| ES2429170T3 (es) | 2005-11-04 | 2013-11-13 | 3M Innovative Properties Company | 1H-Imidazoquinolinas sustituidas con hidroxilo y alcoxilo y métodos |
| US8088788B2 (en) | 2006-03-15 | 2012-01-03 | 3M Innovative Properties Company | Substituted fused[1,2] imidazo[4,5-c] ring compounds and methods |
| US8329721B2 (en) | 2006-03-15 | 2012-12-11 | 3M Innovative Properties Company | Hydroxy and alkoxy substituted 1H-imidazonaphthyridines and methods |
| US8846697B2 (en) | 2006-05-31 | 2014-09-30 | The Regents Of The University Of California | Purine analogs |
| US7906506B2 (en) | 2006-07-12 | 2011-03-15 | 3M Innovative Properties Company | Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods |
| EP2510946B1 (en) | 2007-02-07 | 2015-08-05 | The Regents of The University of California | Conjugates of synthetic tlr agonists and uses therefor |
| AU2008335457B2 (en) | 2007-12-07 | 2015-04-16 | Glaxosmithkline Biologicals S.A. | Compositions for inducing immune responses |
| WO2010088924A1 (en) | 2009-02-06 | 2010-08-12 | Telormedix Sa | Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration |
| US11697851B2 (en) | 2016-05-24 | 2023-07-11 | The Regents Of The University Of California | Early ovarian cancer detection diagnostic test based on mRNA isoforms |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL105325A (en) * | 1992-04-16 | 1996-11-14 | Minnesota Mining & Mfg | Immunogen/vaccine adjuvant composition |
| US6558951B1 (en) * | 1999-02-11 | 2003-05-06 | 3M Innovative Properties Company | Maturation of dendritic cells with immune response modifying compounds |
| GB0023008D0 (en) * | 2000-09-20 | 2000-11-01 | Glaxo Group Ltd | Improvements in vaccination |
-
2002
- 2002-03-19 GB GBGB0206461.6A patent/GB0206461D0/en not_active Ceased
-
2003
- 2003-03-18 US US10/507,055 patent/US20050143284A1/en not_active Abandoned
- 2003-03-18 AU AU2003212369A patent/AU2003212369A1/en not_active Abandoned
- 2003-03-18 CA CA002479315A patent/CA2479315A1/en not_active Abandoned
- 2003-03-18 JP JP2003575997A patent/JP2005526085A/ja active Pending
- 2003-03-18 WO PCT/EP2003/002878 patent/WO2003077944A1/en not_active Ceased
- 2003-03-18 EP EP03708257A patent/EP1485125A1/en not_active Withdrawn
-
2008
- 2008-01-08 US US11/970,738 patent/US20080188469A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105491982B (zh) | 用于增强透皮递送的肽 | |
| JP2005537234A5 (enExample) | ||
| AR035586A1 (es) | Composicion de vacuna, equipo, metodos para incrementar la respuesta inmune, uso de un derivado de 1h-imidazo(4,5-c)quinolin-4-amina en la fabricacion de un medicamento, y combinacion de componentes para la administracion separada, secuencial o concomitante para el uso en la vacunacion de adn | |
| EP1509521B8 (en) | 1h-imidazo[4,5-c]quinoline derivatives for the treatment of protein kinase dependent diseases | |
| WO2005065319A3 (en) | Generally linear effervescent oral fentanyl dosage form and methods of administering | |
| JP2006501240A5 (enExample) | ||
| BRPI0513200A (pt) | uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas | |
| JP2007534728A5 (enExample) | ||
| IL222495A (en) | Use of an isolated human antibody tnfa antibody to create a drug for the treatment of idiopathic inflammatory bowel disease, a pharmaceutical product, kit and pre-loaded syringe containing it | |
| WO2003090686A3 (en) | Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality | |
| HRP20140102T1 (hr) | Cjepivo za prevenciju relapsa raka dojke | |
| CA2514224A1 (en) | Liquid pharmaceutical formulations of palonosetron | |
| AR035867A1 (es) | Una particula semejante a un virus hcv formada por una proteina de envoltura de hcv, un metodo para formar dicha particula, un medicamento que la contiene, una vacuna, un metodo de deteccion, un kit de diagnostico, el uso de cepas de hansenula o saccharomyces para la expresion de una proteina hcv, e | |
| ITMI20031617A1 (it) | Microcapsule a doppio strato di polisaccaridi utilizzabili | |
| WO2005010022A3 (en) | Agonist polypeptide of receptor for zot and zonulin | |
| WO2005084306A3 (en) | Immunogenic compositions for chlamydia pneunomiae | |
| EP1491210A4 (en) | THERAPEUTIC MEDICAMENT USING ANTIBODY PRESENTING HOLES PROTEIN NANOTEHICLES AND HIGH PROTEIN NANOTEHICLES | |
| DK1173476T3 (da) | Funktionelle sojabönneproteiner | |
| EA200400591A1 (ru) | СПОСОБ ВВЕДЕНИЯ ПЕПТИДА ТИМОЗИН α1 | |
| HUP0400340A2 (hu) | Polipeptidek immunogenitásának csökkentésére szolgáló eljárások | |
| NO20053788D0 (no) | Anvendelse av lupin-konglutin for behandlingen av type II diabetes. | |
| ZA200500556B (en) | The pharmaceutical formulation of traditional chinese medicine for abstinence of drug and preparation method and use thereof | |
| DE60112584D1 (de) | Verfahren zur Herstellung einer flüssigen Dosierungseinheit und Kit | |
| EP1583545A4 (en) | PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF PEPTIDES OF HIV GP41 AND ITS THERAPEUTIC USE | |
| MXPA05012826A (es) | Compuestos utiles en la terapia de la enfermedad de alzheimer y formulaciones que los contienen. |